MARC details
| 000 -LEADER |
|---|
| fixed length control field |
02974cam a2200445Mi 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
811378285 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20170328104020.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION |
|---|
| fixed length control field |
m o d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr mn||||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
120530s2013 stka ob 001 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780702053160 (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
0702053163 (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| Cancelled/invalid ISBN |
9780702042997 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| Cancelled/invalid ISBN |
0702042994 |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
.b71556278 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
E7B |
| Transcribing agency |
E7B |
| Modifying agency |
OCLCO |
| -- |
YDXCP |
| -- |
OCLCA |
| -- |
UtOrBLW |
| Description conventions |
rda |
| 049 ## - LOCAL HOLDINGS (OCLC) |
|---|
| Holding library |
OSUU |
| 050 14 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RM301.25 |
| Item number |
.D783 2013eb |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
615.19 |
| Edition number |
23 |
| Item number |
D |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Drug discovery and development : |
| Remainder of title |
technology in transition / |
| Statement of responsibility, etc |
edited by R.G. Hill, H.P. Rang ; foreword by Patrick Vallance. |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
second edition |
| 264 #1 - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
Edinburgh ; |
| -- |
New York : |
| Name of publisher, distributor, etc |
Elsevier/Churchill Livingstone, |
| Date of publication, distribution, etc |
[2013] |
| 264 #4 - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Date of publication, distribution, etc |
c2013. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xiv, 345 pages : |
| Other physical details |
ill. (chiefly color) ; |
| Dimensions |
24 cm |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
unmediated |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
volume |
| Source |
rdacarrier |
| 500 ## - GENERAL NOTE |
|---|
| General note |
pharmacy bookfair2015 |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
The development of the pharmaceutical industry / H.P. Rang -- The nature of disease and the purpose of therapy / H.P. Rang, R.G. Hill -- Therapeutic modalities / H.P. Rang, H. LeVine, R.G. Hill -- The drug discovery process : general principles and some case histories / H.P. Rang, R.G. Hill -- Choosing the project / H.P. Rang, R.G. Hill -- Choosing the target / H.P. Rang, R.G. Hill -- The role of information, bioinformatics and genomics / B. Robson, R. McBurney -- High-throughput screening / D. Cronk -- The role of medicinal chemistry in the drug discovery process / P. Beswick, A. Naylor -- Metabolism and pharmacokinetic optimization strategies in drug discovery / P. Ballard ... [et al.] -- Pharmacology : its role in drug discovery / H.P. Rang -- Biopharmaceuticals / H. LeVine -- Scaffolds : small globular proteins as antibody substitutes / D. Grabulovski, J. Bertschinger -- Drug development : introduction / H.P. Rang, R.G. Hill -- Assessing drug safety / H.P. Rang, R.G. Hill -- Pharmaceutical development / T. Lundqvist, S. Bredenberg -- Clinical development : present and future / C. Keywood -- Clinical imaging in drug development / P.M. Matthews -- Intellectual property in drug discovery and development / P. Grubb -- Regulatory affairs / I. Hogglof, A. Holmgren -- The role of pharmaceutical marketing / V.L. Lawton -- Drug discovery and development : facts and figures / H.P. Rang, R.G. Hill. |
| 588 ## - SOURCE OF DESCRIPTION NOTE |
|---|
| Source of description note |
Description based on print version record. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Drugs |
| General subdivision |
Design. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Drug development. |
| 655 #0 - INDEX TERM--GENRE/FORM |
|---|
| Genre/form data or focus term |
Electronic books. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Hill, R. G. |
| Fuller form of name |
(Raymond G.), |
| Relator term |
editor. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Rang, H. P. |
| Relator term |
editor. |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
|---|
| Display text |
Print version: |
| Title |
Drug discovery and development. |
| Edition |
2nd ed. |
| Place, publisher, and date of publication |
Edinburgh ; New York : Elsevier, 2013 |
| International Standard Book Number |
9780702042997 |
| Record control number |
(DLC) 2012022101 |
| -- |
(OCoLC)748336518. |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Koha item type |
Books |